Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation

Respiratory Research

Volumn 6, Issue , 2005, Pages

  Uller, Lena ^a   Rydell Törmänen, Kristina ^a   Persson, Carl G A ^b   Erjefält, Jonas S ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergy; Apoptosis; Asthma; Chemokines; Eosinophils

Indexed keywords

ALLERGEN; BETA CHEMOKINE; FAS ANTIBODY; FIBRINOGEN; MONOCLONAL ANTIBODY; ANTI-FAS MONOCLONAL ANTIBODY; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DEGRANULATION; DISEASE EXACERBATION; ELECTRON MICROSCOPY; EOSINOPHIL; EXUDATE; HISTOPATHOLOGY; LUNG LAVAGE; MALE; MOUSE; MUCUS SECRETION; NECROSIS; NEUTROPHILIA; NONHUMAN; PROVOCATION TEST; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; IMMUNOLOGY; LUNG; PATHOLOGY; PNEUMONIA;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL DEGRANULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; LUNG; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; PNEUMONIA;

EID: 26244464292     PISSN: 1465993X     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-6-90     Document Type: Article

References (45)

1. Fadok VA, Bratton DL, Henson PM: Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001, 108(7):957-962.
2. Henson PM, Bratton DL, Fadok VA: The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2001, 2(8):627-633.
3. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST: Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003, 111(2):215-225. quiz 226
4. Persson CG: Centennial notions of asthma as an eosinophilic, desquamative, exudative, and steroid-sensitive disease. Lancet 1997, 350(9083):1021-1024.
5. Alam R, Busse WW: The eosinophil - quo vadis? J Allergy Clin Immunol 2004, 113(1):38-42.
6. Ward I, Dransfield I, Chilvers ER, Haslett I, Rossi AG: Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol Sci 1999, 20(12):503-509.
7. Tsuyuki S, Bertrand C, Erard F, Trifilieff A, Tsuyuki J, Wesp M, Anderson GP, Coyle AJ: Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J Clin Invest 1995, 96(6):2924-2931.
8. Meagher LC, Cousin JM, Seckl JR, Haslett C: Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996, 156(11):4422-4428.
9. Schleimer RP, Bochner BS: The effects of glucocorticoids on human eosinophils. J Allergy Clin Immunol 1994, 94(6 Pt 2): 1202-1213.
10. Uller L, Andersson M, Greiff L, Persson CG, Erjefalt JS: Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps. Am J Respir Crit Care Med 2004, 170(7):742-747.
11. Matsumoto K, Schleimer RP, Saito H, Iikura Y, Bochner BS: Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995, 86(4):1437-1443.
12. Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000, 1(6):489-495.
13. Erjefalt JS, Greiff L, Andersson M, Adelroth E, Jeffery PK, Persson CG: Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax 2001, 56(5):341-344.
14. Druilhe A, Cai Z, Haile S, Chouaib S, Pretolani M: Fas-mediated apoptosis in cultured human eosinophils. Blood 1996, 87(7):2822-2830.
15. Hebestreit H, Yousefi S, Balatti I, Weber M, Crameri R, Simon D, Hartung K, Schapowal A, Blaser K, Simon HU: Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur J Immunol 1996, 26(8):1775-1780.
16. Woolley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Woolley MJ: Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Respir Crit Care Med 1996, 154(1):237-243.
17. Anderson GP: Resolution of chronic inflammation by therapeutic induction of apoptosis. Trends Pharmacol Sci 1996, 17(12):438-442.
18. Simon HU: Eosinophil apoptosis - pathophysiologic and therapeutic implications. Allergy 2000, 55(10):910-915.
19. Chuang YH, Fu CL, Lo YC, Chiang BL: Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Ther 2004.
20. Erjefalt JS, Persson CG: New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med 2000, 161(6):2074-2085.
21. Uller L, Persson CG, Kallstrom L, Erjefalt JS: Lung tissue eosinophils may be cleared through luminal entry rather than apoptosis: effects of steroid treatment. Am J Respir Crit Care Med 2001, 164(10 Pt 1):1948-1956.
22. Erjefalt JS, Uller L, Malm-Erjefalt M, Persson CG: Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration. Thorax 2004, 59(2):136-143.
23. Ohta K, Yamashita N, Tajima M, Miyasaka T, Kawashima R, Nakano J, Arioka H, Ishii A, Horiuchi T, Miyamoto T: In vivo effects of apoptosis in asthma examined by a murine model. Int Arch Allergy Immunol 2001, 124(1-3):259-261.
24. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26(4):239-257.
25. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, Bluethmann H: Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994, 24(1):73-80.
26. Korsgren M, Erjefalt JS, Korsgren O, Sundler F, Persson CG: Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med 1997, 185(5):885-892.
27. Ten RM, Pease LR, McKean DJ, Bell MP, Gleich GJ: Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med 1989, 169(5):1757-1769
28. Persson CG, Erjefalt JS: Airway epithelial restitution after shedding and denudation. In THE LUNG Edited by: Crystal RG, West JB. Philadelphia: Lippincort - Raven Publishers; 1997:2611-2627.
29. Erjefalt JS, Andersson M, Greiff L, Korsgren M, Gizycki M, Jeffery PK, Persson GA: Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophils. J Allergy Clin Immunol 1998, 102(2):286-294.
30. Gonzalo JA, Lloyd CM, Wen D, Albar JP, Wells TN, Proudfoot A, Martinez AC, Dorf M, Bjerke T, Coyle AJ, et al.: The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med 1998, 188(1):157-167.
31. Harvey CE, Post JJ, Palladinetti P, Freeman AJ, Ffrench RA, Kumar RK, Marinos G, Lloyd AR: Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. J Leukoc Biol 2003, 74(3):360-369.
32. Elias JA, Zhu Z, Chupp G, Homer RJ: Airway remodeling in asthma. J Clin Invest 1999, 104(8):1001-1006.
33. Persson CG, Erjefalt JS, Korsgren M, Sundler F: The mouse trap. Trends Pharmacol Sci 1997, 18(12):465-467.
34. Malm-Erjefalt M, Persson CG, Erjefalt JS: Degranulation status of airway tissue eosinophils in mouse models of allergic airway inflammation. Am J Respir Cell Mol Biol 2001, 24(3):352-359.
35. Persson CG, Erjefalt JS: Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development. Trends Pharmacol Sci 1997, 18(4):117-123.
36. Shimura S, Andoh Y, Haraguchi M, Shirato K: Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996, 9(7):1395-1401.
37. O'Connell J, Houston A, Bennett MW, O'Sullivan GC, Shanahan F: Immune privilege or inflammation? Insights into the Fas ligand enigma. Nat Med 2001, 7(3):271-274.
38. Hu B, Jennings JH, Sonstein J, Floros J, Todt JC, Polak T, Curtis JL: Resident murine alveolar and peritoneal macrophages differ in adhesion of apoptotic thymocytes. Am J Respir Cell Mol Biol 2004, 30(5):687-693.
39. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995, 146(1):3-15.
40. Clark K, Simson L, Newcombe N, Koskinen AM, Mattes J, Lee NA, Lee JJ, Dent LA, Matthaei KI, Foster PS: Eosinophil degranulation in the allergic lung of mice primarily occurs in the airway lumen. J Leukoc Biol 2004, 75(6):1001-1009.
41. Persson CG, Erjefalt JS: Degranulation in eosinophils in human, but not in mouse, airways. Allergy 1999, 54(11):1230-1232.
42. Denzler KL, Borchers MT, Crosby JR, Cieslewicz G, Hines EM, Justice JP, Cormier SA, Lindenberger KA, Song W, Wu W, et al.: Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol 2001, 167(3):1672-1682.
43. Lukacs NW: Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001, 1(2):108-116.
44. Wenzel SE, Balzar S, Cundall M, Chu HW: Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J Allergy Clin Immunol 2003, 111(6):1345-1352.
45. Miwa K, Asano M, Horai R, Iwakura Y, Nagata S, Suda T: Caspase 1-independent IL-1beta release and inflammation induced by the apoptosis inducer Fas ligand. Nat Med 1998, 4(11):1287-1292.